Polyclonal Antibody of 200 µl targeting ELAVL1/HuR for IP, RIP, WB.
| Product Specifications | |
| Application | IP, WB, RIP |
| Reactivity | Human, Mouse, Rat, Hamster |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | Peptide bond synthesis MSNGYEDHMAEDCRGDIGR KLH (1-19 aa) |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Gene ID - Rat | |
| Formulation | 200 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Citations for Anti-ELAVL1 (HuR) (Human) pAb – 10 Found |
| Williams, Timothy K; Costantino, Christina L; Bildzukewicz, Nikolai A; Richards, Nathan G; Rittenhouse, David W; Einstein, Lisa; Cozzitorto, Joseph A; Keen, Judith C; Dasgupta, Abhijit; Gorospe, Myriam; Gonye, Gregory E; Yeo, Charles J; Witkiewicz, Agnieszka K; Brody, Jonathan R. pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. Plos One. 2010;5(11):e15455. PubMed - Comments: Used in: RIP |
| Onomoto, Koji; Jogi, Michihiko; Yoo, Ji-Seung; Narita, Ryo; Morimoto, Shiho; Takemura, Azumi; Sambhara, Suryaprakash; Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke; Matsumiya, Tomoh; Namiki, Hideo; Yoneyama, Mitsutoshi; Fujita, Takashi. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. Plos One. 7(8):e43031. PubMed - Comments: Used in: WB |
| Pineda, Danielle M; Rittenhouse, David W; Valley, Christopher C; Cozzitorto, Joseph A; Burkhart, Richard A; Leiby, Benjamin; Winter, Jordan M; Weber, Matthew C; Londin, Eric R; Rigoutsos, Isidore; Yeo, Charles J; Gorospe, Myriam; Witkiewicz, Agnieska K; Sachs, Jonathan N; Brody, Jonathan R. HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells. Cancer Biology & Therapy. 2012;13(10):946-55. PubMed - Comments: Used in: RIP |
| Banadakoppa, Manu; Liebenthal, Daniel; Nowak, David E; Urvil, Petri; Yallampalli, Uma; Wilson, Gerald M; Kishor, Aparna; Yallampalli, Chandra. Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide. The Febs Journal. 2013;280(3):840-54. PubMed - Comments: Used in: RIP |
| Jimbo, Masaya; Blanco, Fernando F; Huang, Yu-Hung; Telonis, Aristeidis G; Screnci, Brad A; Cosma, Gabriela L; Alexeev, Vitali; Gonye, Gregory E; Yeo, Charles J; Sawicki, Janet A; Winter, Jordan M; Brody, Jonathan R. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015;6(29):27312-31. PubMed - Comments: Used in: RIP |
| Suhl, Joshua A; Muddashetty, Ravi S; Anderson, Bart R; Ifrim, Marius F; Visootsak, Jeannie; Bassell, Gary J; Warren, Stephen T. A 3' untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR. Proceedings Of The National Academy Of Sciences Of The United States Of America. 2015;112(47):E6553-61. PubMed - Comments: Used in: RIP |
| Huang, Yu-Hung; Peng, Weidan; Furuuchi, Narumi; DuHadaway, James B; Jimbo, Masaya; Pirritano, Andrea; Dunton, Charles J; Daum, Gary S; Leiby, Benjamin E; Brody, Jonathan R; Sawicki, Janet A. Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy. Oncotarget. 2016;7(16):21812-24. PubMed - Comments: Used in: RIP |
| Romeo, Carmella; Weber, Matthew C; Zarei, Mahsa; DeCicco, Danielle; Chand, Saswati N; Lobo, Angie D; Winter, Jordan M; Sawicki, Janet A; Sachs, Jonathan N; Meisner-Kober, Nicole; Yeo, Charles J; Vadigepalli, Rajanikanth; Tykocinski, Mark L; Brody, Jonathan R. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells. Molecular Cancer Research : Mcr. 2016;14(7):599-611. PubMed - Comments: Used in: RIP |
| Popovitchenko, T; Thompson, K; Viljetic, B; Jiao, X; Kontonyiannis, D L; Kiledjian, M; Hart, R P; Rasin, M R. The RNA binding protein HuR determines the differential translation of autism-associated FoxP subfamily members in the developing neocortex. Scientific Reports. 2016;6:28998. PubMed - Comments: Used in: RIP |
| Zhou, H; Telonis, A G; Jing, Y; Xia, N L; Biederman, L; Jimbo, M; Blanco, F; Londin, E; Brody, J R; Rigoutsos, I. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Cell Death & Disease. 2016;7(7):e2294. PubMed - Comments: Used in: RIP |